Some writers with higher expression in BLCA were also risk factors, such as TRMT61B, NUDT21, CSTF1/2, and CPSF2/3, while ADARB2 was the only protective factor with lower expression in BLCA. Here, NUDT21 is linked to bladder transitional cell carcinoma.